Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Feb 20

PMID 26894429

Citations 7

Authors

Se Eun Park

Cheol-Young Park

Jung Mook Choi

Eugene Chang

Eun-Jung Rhee

Won-Young Lee

Ki Won Oh

Sung Woo Park

Eun Seok Kang

Hyun Chul Lee

Bong Soo Cha

Affiliations

Soon will be listed here.

Abstract

Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic dysfunction. PPARγ agonist was reported to improve insulin sensitivity by redistributing fat from visceral fat to subcutaneous fat. The purpose of this study was to investigate the underlying mechanisms by which aging affects adipose tissue remodeling in a type 2 diabetic animal model and through which PPARγ activation modulates aging-related fat tissue distribution. At the ages of 21, 31 and 43 weeks, OLETF rats as an animal model of type 2 diabetes were evaluated for aging-related effects on adipose tissue metabolism in subcutaneous and visceral fat depots. During aging, the ratio of visceral fat weight to subcutaneous fat weight (V/S ratio) increased. Aging significantly increased the mRNA expression of genes involved in lipogenesis such as lipoprotein lipase, fatty acid binding protein aP2, lipin 1, and diacylglycerol acyltransferase 1, which were more prominent in visceral fat than subcutaneous fat. The mRNA expression of adipose triglyceride lipase, which is involved in basal lipolysis and fatty acid recycling, was also increased, more in visceral fat compared to subcutaneous fat during aging. The mRNA levels of the genes associated with lipid oxidation were increased, whereas the mRNA levels of genes associated with energy expenditure showed no significant change during aging. PPARγ agonist treatment in OLETF rats resulted in fat redistribution with a decreasing V/S ratio and improved glucose intolerance. The genes involved in lipogenesis decreased in visceral fat of the PPARγ agonist-treated rats. During aging, fat distribution was changed by stimulating lipid uptake and esterification in visceral fat rather than subcutaneous fat, and by altering the lipid oxidation.

Citing Articles

Exposure to Volatile Organic Compounds in Relation to Visceral Adiposity Index and Lipid Accumulation Product Among U.S. Adults: NHANES 2011-2018.

Qian Z, Dai C, Chen S, Yang L, Huo X Toxics. 2025; 13(1).

PMID: 39853044 PMC: 11768580. DOI: 10.3390/toxics13010046.

Association of epicardial adipose tissue with metabolic risk factors on cardiovascular outcomes: serial coronary computed tomography angiography study.

Park S, Kim D, Kim S, Choi J, Park S, Lee H Korean J Intern Med. 2024; 39(2):283-294.

PMID: 38351679 PMC: 10918372. DOI: 10.3904/kjim.2023.389.

Adipose Tissue Aging and Metabolic Disorder, and the Impact of Nutritional Interventions.

Wang X, Xu M, Li Y Nutrients. 2022; 14(15).

PMID: 35956309 PMC: 9370499. DOI: 10.3390/nu14153134.

Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction.

Le Pelletier L, Mantecon M, Gorwood J, Auclair M, Foresti R, Motterlini R Elife. 2021; 10.

PMID: 34544550 PMC: 8526089. DOI: 10.7554/eLife.62635.

Aging selectively dampens oscillation of lipid abundance in white and brown adipose tissue.

Held N, Buijink M, Elfrink H, Kooijman S, Janssens G, Luyf A Sci Rep. 2021; 11(1):5932.

PMID: 33723320 PMC: 7961067. DOI: 10.1038/s41598-021-85455-4.

References

Kalderon B, Mayorek N, Bar-Tana J . Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo. Am J Physiol Endocrinol Metab. 2002; 284(4):E795-803. DOI: 10.1152/ajpendo.00368.2002. View

Harris R, Zhou J, Redmann Jr S, Smagin G, Smith S, Rodgers E . A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology. 1998; 139(1):8-19. DOI: 10.1210/endo.139.1.5675. View

Hughes V, Roubenoff R, Wood M, Frontera W, Evans W, Fiatarone Singh M . Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr. 2004; 80(2):475-82. DOI: 10.1093/ajcn/80.2.475. View

Lyon C, Law R, Hsueh W . Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144(6):2195-200. DOI: 10.1210/en.2003-0285. View

Cadoudal T, Distel E, Durant S, Fouque F, Blouin J, Collinet M . Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes. 2008; 57(9):2272-9. PMC: 2518477. DOI: 10.2337/db08-0477. View

Ravaglia G, Forti P, Maioli F, Boschi F, Cicognani A, Gasbarrini G . Measurement of body fat in healthy elderly men: a comparison of methods. J Gerontol A Biol Sci Med Sci. 1999; 54(2):M70-6. DOI: 10.1093/gerona/54.2.m70. View

Festuccia W, Laplante M, Berthiaume M, Gelinas Y, Deshaies Y . PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia. 2006; 49(10):2427-36. DOI: 10.1007/s00125-006-0336-y. View

Coort S, Coumans W, Bonen A, Van der Vusse G, Glatz J, Luiken J . Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J Lipid Res. 2005; 46(6):1295-302. DOI: 10.1194/jlr.M400426-JLR200. View

Zou Z, Ye J, Sayama K, Arakawa H . Direct splitting of water under visible light irradiation with an oxide semiconductor photocatalyst. Nature. 2001; 414(6864):625-7. DOI: 10.1038/414625a. View

10.

Laplante M, Festuccia W, Soucy G, Gelinas Y, Lalonde J, Berger J . Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes. 2006; 55(10):2771-8. DOI: 10.2337/db06-0551. View

11.

Goodpaster B, Krishnaswami S, Harris T, Katsiaras A, Kritchevsky S, Simonsick E . Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005; 165(7):777-83. DOI: 10.1001/archinte.165.7.777. View

12.

Yu C, Chen Y, Cline G, Zhang D, Zong H, Wang Y . Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002; 277(52):50230-6. DOI: 10.1074/jbc.M200958200. View

13.

Holness M, Sugden M . Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans. 2003; 31(Pt 6):1143-51. DOI: 10.1042/bst0311143. View

14.

DeNino W, Tchernof A, Dionne I, Toth M, Ades P, Sites C . Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001; 24(5):925-32. DOI: 10.2337/diacare.24.5.925. View

15.

Tordjman J, Chauvet G, Quette J, Beale E, Forest C, Antoine B . Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 2003; 278(21):18785-90. DOI: 10.1074/jbc.M206999200. View

16.

Reue K, Zhang P . The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett. 2007; 582(1):90-6. PMC: 2848953. DOI: 10.1016/j.febslet.2007.11.014. View

17.

Wajchenberg B . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2001; 21(6):697-738. DOI: 10.1210/edrv.21.6.0415. View

18.

Guo S, Zeller C, Chumlea W, Siervogel R . Aging, body composition, and lifestyle: the Fels Longitudinal Study. Am J Clin Nutr. 1999; 70(3):405-11. DOI: 10.1093/ajcn/70.3.405. View

19.

Oakes N, Thalen P, Jacinto S, LJUNG B . Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes. 2001; 50(5):1158-65. DOI: 10.2337/diabetes.50.5.1158. View

20.

Herrero-Gonzalez S, Valle-Casuso J, Sanchez-Alvarez R, Giaume C, Medina J, Tabernero A . Connexin43 is involved in the effect of endothelin-1 on astrocyte proliferation and glucose uptake. Glia. 2008; 57(2):222-33. DOI: 10.1002/glia.20748. View